Streetbeat News

Regulatory

SMCI

Super Micro's stock is experiencing a significant decline, with shares expected to drop over 20% due to the company's announcement of a filing delay that could impact its business.

Portfolio Pulse from

November 06, 2024 | 3:30 pm

CURLF

VRNOF

Cannabis stocks, including Trulieve Cannabis Corp., Curaleaf Holdings Inc., and Verano Holdings Corp, saw a decline after Florida voters rejected a measure to legalize recreational marijuana.

Portfolio Pulse from

November 06, 2024 | 3:00 pm

EXPRQ

American Express Global Business Travel has acknowledged the U.K. Competition and Markets Authority's interim report concerning its acquisition of CWT.

Portfolio Pulse from

November 06, 2024 | 2:45 pm

F

Donald Trump's reelection could lead to uncertainty in the U.S. auto industry, particularly affecting electric vehicles (EVs), as Republicans criticize EVs and their impact on the industry.

Portfolio Pulse from

November 06, 2024 | 2:45 pm

BNO

U.S. oil producers anticipate fewer regulations under Trump, potentially increasing oil supply and lowering prices. However, Trump's proposed sanctions on Iran and Venezuela could tighten the global market, possibly boosting prices.

Portfolio Pulse from

November 06, 2024 | 2:45 pm

AAWH

The election of Donald Trump as president raises concerns about the future of cannabis reform, which could impact marijuana stocks. Investors are worried that Trump may not pursue federal cannabis reform as aggressively as Kamala Harris might have, despite the fact that more than half of the U.S. has legalized cannabis.

Portfolio Pulse from

November 06, 2024 | 2:30 pm

ARM

ASML

STM

Citi analysts warn that Arm Holdings, Infineon Technologies, STMicroelectronics, and ASML Holding could face risks from a potential Trump presidency due to possible higher tariffs and changes to the Inflation Reduction and CHIPS Acts.

Portfolio Pulse from

November 06, 2024 | 2:00 pm

DJIA

NDAQ

SPX

The US stock markets, including NASDAQ, Dow Jones, and S&P 500, have surged following a landslide election victory for Trump. Investors are now anticipating the upcoming Federal Reserve interest rate decision on Thursday.

Portfolio Pulse from

November 06, 2024 | 2:00 pm

SONN

Sonnet BioTherapeutics has announced the issuance of a U.S. patent for a variant IL-18 incorporated into two novel immunotherapeutic drug candidates, SON-1411 and SON-1400. These proteins show wild-type binding to the IL-18 receptor while avoiding binding to the inhibitory IL-18 binding protein.

Portfolio Pulse from

November 06, 2024 | 1:45 pm